 
|
 |
17 ALPHA HYDROXYPROGESTERONE CAPROATE, (17P), PREVENTS PRETERM BIRTH IN WOMEN AT HIGH RISK
PAUL J. MEIS FOR THE NICHD MFMU NETWORK, BETHESDA MD
Objective
Although early small studies suggested a benefit for 17P therapy in preventing preterm birth, no large rigorous trial has confirmed these data. The current study was undertaken to answer this question.
Study Design
Women with at documented history of a previous spontaneous preterm birth at less that 37 weeks gestational age were enrolled at 19 Centers at 16 to 20 weeks gestation and randomly assigned by a central data center using a 2 to 1 ratio to weekly injections of 17P or to a placebo injection, with treatment continuing to 36 weeks gestation.
Results
The predominant race of the subjects was African-American, (59%). Mean gestational age at birth of the qualifying delivery was 30.7 weeks. Baseline characteristics of the treatment group, n=306, and the placebo group, n=153, were similar. Treatment with 17P significantly reduced the risk of preterm birth at <37 weeks, <35 weeks and <32 weeks gestation. Treatment with 17P was equally effective in African American and non-African American subjects.
Conslusions
Weekly injections of 17P can provide a significant and powerful protection to prevent recurrent preterm birth in women at high risk.
|
Placebo |
17P |
Relative risk |
Conf. Int. |
p |
| n |
153 |
306 |
|
|
|
| <37 wks |
54.9% |
36.3% |
0.66 |
(0.54-0.81) |
0.0001 |
| <35 wks |
30.7% |
20.6% |
0.67 |
(0.498-0.93) |
0.0165 |
| <32 wks |
19.6% |
11.4% |
0.58 |
(0.37-0.91) |
0.0180 |
|
The information contained on this site
is general in nature and is intended for use as an informational aid. It does
not cover all possible uses, actions, precautions, side effects, or interactions
of the products shown, nor is the information intended as medical advice or
diagnosis for individual health problems or for making an evaluation as to the
risks and benefits of using a particular product. You should consult your doctor
about diagnosis and treatment of any health problems. Information and statements
have not been evaluated by the Food and Drug Administration ("FDA"),
nor has the FDA approved the products to diagnose, cure or prevent disease.
Our toll-free fax number is 800-589-4250.
Request a Brochure
| Request a Formulation Consultation
Compound Medications | Veterinary
Medicine | Compounding Pharmacy | Veterinary
Medications
Information on Expired Medications | Sitemap
Featured Medication: Avastin,
Hydroxyprogesterone, Tri-Mix
Featured Monographs: Metronidazole,
Pentosan, Trilostane
405 Heron Drive Suite 200 Swedesboro, NJ 08085-1749 1-888-678-1967
Copyright © 2004-2008 Wedgewood Village Pharmacy, Inc. All rights reserved.
|